Hosted on MSN11mon
CRISPR-based gene editing therapy approved by the FDA for the first time
While both drug approvals use gene editing techniques, Casgevy’s CRISPR/Cas9 genome editing works by cutting out or splicing in DNA in select areas. Patients first have blood drawn so that their ...
Hosted on MSN10mon
HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia
Using CRISPR/Cas9 screening, the researchers identified ... To the researchers' surprise, splicing factors appeared to be the most represented pathway. "This was quite surprising to us because ...